Edgardo Rodriguez-Lebron

Form D signer

Edgardo Rodriguez-Lebron

Chief Executive Officer at iOncologi

Form D signer

Capital raised by iOncologi

$3.3M+$250K latest round

2 Form D filings · first filed Feb 2025 · Gainsville, FL

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 4
FOUNDED: —
30D INTEREST: —

Career

1 company on file

iOncologiBiotech · Gainsville, FLsince Feb 2025

Chief Executive Officer

Signatory on iOncologi's Form D filings · $3.3M raised across 2

Company filings

via EDGAR · Form D for iOncologi2

DateCompanyFormAmountRole on filing

May 8, 2025iOncologiForm D+$250KChief Executive Officer

Form DMay 8, 2025 · iOncologi+$250Kas Chief Executive Officer

Feb 18, 2025iOncologiForm D+$3.0MChief Executive Officer

Form DFeb 18, 2025 · iOncologi+$3.0Mas Chief Executive Officer

Overview

Last filing May 8, 2025

Edgardo Rodriguez-Lebron is on file as Chief Executive Officer at iOncologi in Gainsville, FL. iOncologi has 2 Form D filings on record, $3.3M raised in total. Edgardo Rodriguez-Lebron appears as a signatory on the company's filings.

Teammates

iOncologi · 3

Catherine FloresDirector Edgardo RodriguezChief Executive OfficerSigner Mona FloresDirector

Products

iOncologi · 1

IONC201 and IONC202Immunotherapy

IONC201 and IONC202 are advanced immunomodulatory stem cell therapies specifically designed to circumvent resistance to PD-1 blockade. They work by enhancing anti-tumor immune responses, offering a promising solution for patients who exhibit resistance to traditional immunotherapy.